Kaken Pharmaceutical News and Activities
Presence
Kaken Pharmaceutical develops, manufactures, and sells prescription medicines and related healthcare products. Its main products serve hospitals, clinics, and patients in areas such as dermatology, orthopedics, and infectious diseases.
Kaken Pharmaceutical products and services overview:
- Prescription medicines
- Dermatology treatments
- Orthopedic treatments
- Antifungal medicines
- Pain management
- Healthcare products
Revenue: ~$560 million
Employees: 1,300
Headquarters: Tokyo, Japan
Kaken Pharmaceutical is one of the...
Kaken Pharmaceutical is a company listed under the stock ticker 4521 (JP).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Kaken Pharmaceutical
- Hiroyuki Horiuchi, President and Representative Director
- Yasuhiro Umeda, Director
- Yasutomo Inoue, Independent Director
Create your alert
to follow the executive moves at Kaken Pharmaceutical.
Pharmaceuticals
Kaken Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Kaken Pharmaceutical
Social media about Kaken Pharmaceutical
- Kaken Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Kaken Pharmaceutical on LinkedIn, X (Twitter) & YouTube
